215 related items for PubMed ID: 10531156
1. Evaluation of the effect of a large volume spacer on the systemic bioactivity of fluticasone propionate metered-dose inhaler.
Dempsey OJ, Wilson AM, Coutie WJ, Lipworth BJ.
Chest; 1999 Oct; 116(4):935-40. PubMed ID: 10531156
[Abstract] [Full Text] [Related]
2. Relative lung delivery of fluticasone propionate via large volume spacer or nebuliser in healthy volunteers.
Dempsey OJ, Humphreys M, Coutie WJ, Lipworth BJ.
Eur J Clin Pharmacol; 2001 Nov; 57(9):637-41. PubMed ID: 11791892
[Abstract] [Full Text] [Related]
3. In vivo comparison of the relative systemic bioavailability of fluticasone propionate from three anti-static spacers and a metered dose inhaler.
Nair A, Menzies D, Hopkinson P, McFarlane L, Lipworth BJ.
Br J Clin Pharmacol; 2009 Feb; 67(2):191-8. PubMed ID: 19220273
[Abstract] [Full Text] [Related]
4. Evaluation of the buccal component of systemic absorption with inhaled fluticasone propionate.
Dempsey OJ, Coutie WJ, Wilson AM, Williams P, Lipworth BJ.
Thorax; 1999 Jul; 54(7):614-7. PubMed ID: 10377207
[Abstract] [Full Text] [Related]
5. Systemic bioavailability of hydrofluoroalkane (HFA) formulations of fluticasone/salmeterol in healthy volunteers via pMDI alone and spacer.
Clearie KL, Williamson PA, Vaidyanathan S, Du Bois J, Nell H, Lipworth BJ.
Br J Clin Pharmacol; 2010 Jun; 69(6):637-44. PubMed ID: 20565455
[Abstract] [Full Text] [Related]
6. Dose-response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate.
Fowler SJ, Orr LC, Wilson AM, Sims EJ, Lipworth BJ.
Br J Clin Pharmacol; 2001 Jul; 52(1):93-5. PubMed ID: 11453895
[Abstract] [Full Text] [Related]
7. Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children.
Lipworth BJ, Clark DJ, McFarlane LC.
Thorax; 1997 Aug; 52(8):686-9. PubMed ID: 9337826
[Abstract] [Full Text] [Related]
8. Adrenocortical activity with repeated administration of one-daily inhaled fluticasone propionate and budesonide in asthmatic adults.
Wilson AM, Clark DJ, Devlin MM, McFarlane LC, Lipworth BJ.
Eur J Clin Pharmacol; 1998 Jan; 53(5):317-20. PubMed ID: 9516029
[Abstract] [Full Text] [Related]
9. Adrenal suppression with high doses of inhaled fluticasone propionate and triamcinolone acetonide in healthy volunteers.
Wilson AM, Clark DJ, McFarlane L, Lipworth BJ.
Eur J Clin Pharmacol; 1997 Jan; 53(1):33-7. PubMed ID: 9349927
[Abstract] [Full Text] [Related]
10. A novel breath-actuated integrated vortex spacer device increases relative lung bioavailability of fluticasone/salmeterol in combination.
Nair A, Clearie K, Menzies D, Meldrum K, McFarlane L, Lipworth BJ.
Pulm Pharmacol Ther; 2009 Aug; 22(4):305-10. PubMed ID: 19489129
[Abstract] [Full Text] [Related]
11. Short-Term Growth During Treatment with Inhaled Fluticasone Propionate/Formoterol, Fluticasone and Beclomethasone Treatment.
Wolthers OD, Moore A, Mersmann S, Dissanayake S.
J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):373-380. PubMed ID: 28510491
[Abstract] [Full Text] [Related]
12. Systemic bioavailability and potency of high-dose inhaled corticosteroids: a comparison of four inhaler devices and three drugs in healthy adult volunteers.
Wales D, Makker H, Kane J, McDowell P, O'Driscoll BR.
Chest; 1999 May; 115(5):1278-84. PubMed ID: 10334140
[Abstract] [Full Text] [Related]
13. Single-dose and steady-state pharmacokinetic and pharmacodynamic evaluation of therapeutically clinically equivalent doses of inhaled fluticasone propionate and budesonide, given as Diskus or Turbohaler dry-powder inhalers to healthy subjects.
Möllmann H, Wagner M, Krishnaswami S, Dimova H, Tang Y, Falcoz C, Daley-Yates PT, Krieg M, Stöckmann R, Barth J, Lawlor C, Möllmann AC, Derendorf H, Hochhaus G.
J Clin Pharmacol; 2001 Dec; 41(12):1329-38. PubMed ID: 11762560
[Abstract] [Full Text] [Related]
14. Nocturnal cortisol secretion in asthmatic patients after inhalation of fluticasone propionate.
Weiner P, Berar-Yanay N, Davidovich A, Magadle R.
Chest; 1999 Oct; 116(4):931-4. PubMed ID: 10531155
[Abstract] [Full Text] [Related]
15. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
Lee DK, Fardon TC, Bates CE, Haggart K, McFarlane LC, Lipworth BJ.
Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
[Abstract] [Full Text] [Related]
16. Pharmacokinetics of epimeric budesonide and fluticasone propionate after repeat dose inhalation--intersubject variability in systemic absorption from the lung.
Minto C, Li B, Tattam B, Brown K, Seale JP, Donnelly R.
Br J Clin Pharmacol; 2000 Aug; 50(2):116-24. PubMed ID: 10930963
[Abstract] [Full Text] [Related]
17. Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients.
Clark DJ, Lipworth BJ.
Thorax; 1997 Jan; 52(1):55-8. PubMed ID: 9039246
[Abstract] [Full Text] [Related]
18. Adrenal suppression in asthmatic children receiving low-dose inhaled budesonide: comparison between dry powder inhaler and pressurized metered-dose inhaler attached to a spacer.
Goldberg S, Einot T, Algur N, Schwartz S, Greenberg AC, Picard E, Virgilis D, Kerem E.
Ann Allergy Asthma Immunol; 2002 Dec; 89(6):566-71. PubMed ID: 12487221
[Abstract] [Full Text] [Related]
19. Fluticasone propionate via the Diskhaler or hydrofluoroalkane-134a metered-dose inhaler on methacholine-induced airway hyperresponsiveness.
Langley SJ, Holden J, Derham A, Hedgeland P, Sharma RK, Woodcock A.
Chest; 2002 Sep; 122(3):806-11. PubMed ID: 12226017
[Abstract] [Full Text] [Related]
20. Short-term dose-response relationships for the relative systemic effects of oral prednisolone and inhaled fluticasone in asthmatic adults.
Wilson AM, Lipworth BJ.
Br J Clin Pharmacol; 1999 Oct; 48(4):579-85. PubMed ID: 10583029
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
